Holen Sie sich die Stockscreener-App
2.285
18.68%
-0.525
Handel nachbörslich:
2.32
0.035
+1.53%
Schlusskurs vom Vortag:
$2.81
Offen:
$2.78
24-Stunden-Volumen:
61,486
Relative Volume:
2.62
Marktkapitalisierung:
$3.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.66M
KGV:
-3.8077
EPS:
-0.6001
Netto-Cashflow:
$-2.83M
1W Leistung:
+6.40%
1M Leistung:
-0.63%
6M Leistung:
-49.58%
1J Leistung:
-46.92%
1-Tages-Spanne:
$2.25
$2.78
1-Wochen-Bereich:
$1.94
$3.00
52-Wochen-Spanne:
$1.725
$7.05
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Firmenname
Xortx Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare XRTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
2.285 | 3.91M | 0 | -2.66M | -2.83M | -0.6001 |
VRTX
Vertex Pharmaceuticals Inc
|
446.78 | 112.92B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
767.85 | 81.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
800.50 | 48.82B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.28 | 43.66B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.42 | 34.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xortx Therapeutics Inc Aktie (XRTX) Neueste Nachrichten
Aug Update: Can XORTX Therapeutics Inc continue delivering strong returnsWeekly Trade Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Bond Watch: Is XORTX Therapeutics Inc a speculative investmentWall Street Watch & Low Risk Entry Point Tips - baoquankhu1.vn
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – TRADEGATE:ANU - TradingView
XORTX Therapeutics, Inc. Revenue Breakdown – LS:A427MJ - TradingView
Tangible book value per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Balance Sheet – LS:A427MJ - TradingView
XORTX Therapeutics, Inc. Dividends – LS:A427MJ - TradingView
Operating margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Discontinued operations of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
EBITDA margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Gross profit of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Cash from investing activities of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
XORTX Therapeutics, Inc. Cash Flow – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Cash Flow – LS:A427MJ - TradingView
Net income before discontinued operations of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Diluted earnings per share (diluted EPS) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Non-operating income (total) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
EBIT per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
EBITDA margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Net margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Enterprise value to EBITDA ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Net current asset value per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Operating margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Non-controlling/minority interest of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Price to cash flow ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Price to cash flow ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
CapEx per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Total common shares outstanding of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
XORTX Therapeutics, Inc. Statistics – LS:A427MJ - TradingView
Total revenue of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Equity in earnings of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Diluted shares outstanding of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Non-operating income (total) of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Balance Sheet – LSX:A427MJ - TradingView
Debt to equity ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Diluted earnings per share (diluted EPS) of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Gross margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Net current asset value per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Non-controlling/minority interest of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Enterprise value of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Net margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Current ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Net income before discontinued operations of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Operating cash flow per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Financial Statements – LS:A427MJ - TradingView
EBITDA per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Earnings and Revenue – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Earnings and Revenue – LS:A427MJ - TradingView
Price to book ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
CapEx per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Finanzdaten der Xortx Therapeutics Inc-Aktie (XRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.57%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):